BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20261029T033323EDT-1046Xt4G1F@132.216.98.100
DTSTAMP:20261029T073323Z
DESCRIPTION:Revolutionizing Breast Cancer Treatment: MUHC's Global Leadersh
 ip in Phase 3 Clinical Trials with Antibody-Drug Conjugates for Triple-Neg
 ative Breast Cancer – Paving the Way Forward\n\nSpeaker: Dr Jamil Asselah
 \n\nAssociate Professor\, Medical Oncologist MUHC\n\n \n\nAt the end of th
 e presentation\, the audience will:\n\n1. Highlight Antibody-Drug Conjugat
 es (ADCs): Educate the audience about the application and significance of 
 Antibody-Drug Conjugates in the context of breast cancer treatment\, empha
 sizing their potential impact on Triple-Negative Breast Cancer.\n\n2. Show
 case Progress in Clinical Trials: Present the advancements and outcomes of
  Phase 3 Clinical Trials\, showcasing the progress made in research and de
 velopment for breast cancer treatments\, particularly for Triple-Negative 
 Breast Cancer.\n\n3. Provide Insight into MUHC's Global Leadership: Share 
 information about the MUHC significant role and expertise in leading globa
 l efforts related to Phase 3 Clinical Trials.\n\n4. Discuss Global Implica
 tions: Discuss how the findings and progress made in these trials have bro
 ader implications globally\, contributing to the ongoing efforts to enhanc
 e breast cancer treatment options worldwide. \n\n5. Illustrate the Future 
 Landscape: Offer insights into the future of breast cancer treatment by pa
 ving the way forward. Discuss potential implications for clinical practice
 \, patient care\, and the overall landscape of breast cancer research and 
 treatment.\n\nZoom link: https://mcgill.zoom.us/j/84083444054?pwd=NXFkOEdo
 bXk3MUtuUkFKb09OckNaZz09\n\nFull MUHC Grand Rounds Schedule\n
DTSTART:20240123T170000Z
DTEND:20240123T180000Z
SUMMARY:Revolutionizing Breast Cancer Treatment: MUHC's Global Leadership i
 n Phase 3 Clinical Trials with Antibody-Drug Conjugates for Triple-Negativ
 e Breast Cancer – Paving the Way Forward
URL:https://www.mcgill.ca/deptmedicine/channels/event/revolutionizing-breas
 t-cancer-treatment-muhcs-global-leadership-phase-3-clinical-trials-antibod
 y-354126
END:VEVENT
END:VCALENDAR